BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Expression data from breast cancer tumor-initiating cells

Dataset: Expression data from breast cancer tumor-initiating cells

We have generated tumorigenic (S2N) and non-tumorigenic (S2), normal-like to basal-like breast cancer cell lines from primary tumors. At...

Registered by ArrayExpress Uploader
View Dataset

We have generated tumorigenic (S2N) and non-tumorigenic (S2), normal-like to basal-like breast cancer cell lines from primary tumors. At high in vivo inoculation cell numbers of 10^6 cells/mouse both S2N and S2 monolayer as well as sphere culture cells grew at similar rates. However, at low inoculation cell numbers down to 10^3 cells only S2N sphere cells generated xenograft tumors. mRNA profiling revealed a unique cluster pattern of the tumorigenic S2N sphere cells, but a detailed analysis of TIC relevant transcription factors like Oct3, Sox and Nanog family members, Myc, Slug or Twist1 revealed no consistently increased expression in the highly tumorigenic cell lines. Our data indicate that the intrinsic genetic and functional markers investigated are not solely indicative of the in vivo tumorigenicity of putative breast tumor-initiating cells. 4 samples with 3 replicates each

Species:
human

Samples:
12

Source:
E-GEOD-32526

PubMed:
23042145

Updated:
Dec.12, 2014

Registered:
Jul.12, 2014


Factors: (via ArrayExpress)
Sample SAMPLE TYPE CELL LINE
GSM805513 monolayer S2N
GSM805513 monolayer S2N
GSM805513 monolayer S2N
GSM805510 spheres S2N
GSM805510 spheres S2N
GSM805510 spheres S2N
GSM805507 monolayer S2
GSM805507 monolayer S2
GSM805507 monolayer S2
GSM805504 spheres S2
GSM805504 spheres S2
GSM805504 spheres S2

Tags

  • basal
  • breast
  • breast cancer
  • cancer
  • cell

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2025 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use